Abstract
The cardiovascular effects of excess thyroid hormone were first described by Parry 200 years ago (1), and the effects of thyroid deficiency have similarly been long recognized (2). Since the cardiac effects of thyroid hormone excess and deficiency are prominent, considerable research has focused on the mechanism by which thyroid hormone induces these changes. A number of reviews have been published which summarize the clinical and experimental literature regarding thyroid hormone effects on the heart (3–5). The intent of this chapter is to present the principal areas of investigation concerned with the effects of thyroid hormone action on the heart. Clinical and experimental consequences of thyroid disease on the heart are briefly presented, followed by a review of molecular and subcellular effects of thyroid hormone. Research directed towards understanding the effects of thyroid hormone on these latter two aspects of the heart has led to considerable insight into mechanisms responsible for the behavior of the heart in thyroid disease. Throughout this chapter the hormones of the thyroid gland, 3,5,3’,5’-tetraiodothyronine (thyroxine) and 3,5,3’-triiodothyronine, will be referred to as T4 and T3, respectively, or nondistinctively as thyroid hormone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parry, CH. Collections from Unpublished Medical Writings of Caleb Hillier iParry (vol. 2). London, Underwood, 1825, p. 111
Zondek, H. Das Myxodermherz. Med. Wocheschr. 65: 1180, 1918
Skelton, C.L. The heart and hyperthyroidism. New Eng. J. Med. 307: 1206–1208, 1982
Morkin, E., Flink, I.L. and Goldman, S. Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog. Cardiovasc. Res. 25: 435–464, 1983
Iskandrian, A.S., Hakki, A-H. and Mattleman, S. Cardiac function in hyperthyroidism. Clin. Cardiol. 7: 171–174, 1984
Skelton, C.L. and Sonnenblick, E.H. Heterogeneity of contractile function in cardiac hypertrophy. Circ. Res (Suppl II), 83–96, 1974
Sandler, G. and Wilson, G. Nature and prognosis of heart disease in thyrotoxicosis: A review of 150 patients treated with I. Q. J. Med. 28: 347–51, 1959
Forfar, J.C., Muir, Al., Sawers, S.A. and Toft, A.D. Abnormal left ventricular function in hyperthyroidism: Evidence for a possible reversible cardiomyopathy. New Eng. J. Med. 307: 1165–170, 1982
Forfar, J.C., Matthews, D.M. and Toft, A.D. Delayed recovery of left ventricular function after antithyroid treatment: Further evidence for reversible abnormalities of contractility in hyperthyroidism. Br. Heart J. 52: 215–222, 1984
Werner, S.H. and Braverman, L.E. In. Werner’s The Thyroid: A fundamental and clinical text.Fifth Ed. J.B. Lippincott Co. Philadelphia, 1986, p. 1140.
Burchardt, D., Staub. J.J., Kraenzlin, M. et. al. The systolic time intervals in thyroid dysfunction. Am Heart J. 95: 187–190, 1978
Forfar, J. Muir, A. and Toft, A. Left ventricular function in hypothyroidism. Br. Heart J. 48: 278–282, 1982
Vora, J., O’Malley, B.P., Petersen, S. et. al. Reversible abnormalities of myocardial relaxation in hypothyroidism. J. Clin. Endocrinol. Metab. 61: 269–272, 1985
Streeten, D.H.P., Anderson,Jr., G.H., Howland, T. et.al. Effects of thyroid function on blood pressure: Recognition of hypothyroid hypertension. Hypertension. 11: 78–83, 1988
McConnaughey, M.M., Jones, L.R., Watanabe, A.M. et.al. Thyroxine and propylthiouracil effects on alpha-and beta-adrenergic receptor number, ATPase activities, and sialic acid content of rat cardiac membrane vesicles. J. Cardiovasc. Pharmacol. 1: 609–623, 1979
Ishac, E.J.N. and Pennefather, J.N. The effects of altered thyroid state upon responses mediated by atrial muscarinic receptors in the rat. Br. J. Pharmacol. 79: 451–459, 1983
Simpson, W.W., Rodgers, R.L. and McNeill, J.H. Cardiac responsiveness to alpha and beta adrenergic amines: Effects of carbachol and hypothyroidism. J. Pharmacol. Exp. Ther. 219: 231–234, 1981
MacLeod, K.M. and McNeill, J.H. The influence of altered thyroid hormone levels on guinea pig cardiac adrenoceptors and histamine receptors. Can J. Physiol. Pharmacol.
McNeill, J.H. The effect of triiodothyronine pretreatment on amine-induced rat cardiac phosphorylase activation. J. Pharmacol. Exp. Ther. 161: 40–46, 1968
Takeo, S., Tomomatsu, E. and Sakanashi, M. Changes in cardiac myofibrillar ATPase activity during development of hyperthyroidism in the rabbit. Jpn. Heart J. 25: 113–125, 1984
Buccino, R.A., Spann, J.F., Pool, P.E. et. al. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J. Clin. Invest. 46: 1669–1682, 1967
MacKinnon, R., Gwathmay, J.K., Allen, P.D. et.al. Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle. Circ. Res. 63: 1080–1089, 1988
Marriott, M.L. and McNeill, J.H. Effect of thyroid hormone treatment on responses of the isolated working rat heart. Can. J. Physiol. Pharmacol. 61: 1382–1390, 1983
Bedotto, J.B., Gay, R.G., Graham, S.D., Morkin, E. and Goldman, S. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and Beta adrenoceptor blockade. J. Phamacol. Exp. Ther. 248: 632–636, 1989
Brooks, I., Flynn, S.B., Owen D.A.A. and Underwood, A.H. Changes in cardiac function following administration of thyroid hormones in thyroidectomized rats: Assessment using the isolated working rat heart preparation. J. Cardiovasc. Pharmacol. 7: 290–296, 1985
Rutherford, J.D., Vatner, S.F. and Braunwald, E. Adrenergic control of myocardial contractility in conscious hyperthyroid dogs. Am. J. Physiol. 237: H590 - H596, 1979
Hammond, H.K., White, F.C. Buxton, I.L.O. et. al. Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. Am. J. Physiol. 252: H283 - H290, 1987
Lompre, A-M., Nadal-Ginard, B. and Mandavi, V. Expression of the cardiac ventricular alpha-and beta-myosin heavy chain is developmentally and hormonally regulated. J. Biol. Chem. 259: 6437–6446, 1984
Schwartz, K., Lecarpentier, Y., Martin, J.L. et.al. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J. Mol. Cell. Cardiol. 13: 1071–1075, 1981
Hoh, J.F.Y., McGrath, P.A. and Hale, H.T. Electrophoretic analysis of multiple forms of rat cardiac myosin: effect of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 10: 1053–1076, 1978
Flink, I.L., Rader, J.H. and Morkin, E. Thyroid hormone stimulates synthesis of a cardiac myosin isoenzyme. J. Biol. Chem. 254: 3105–3119, 1979
Gustafson, T.A., Markham, B.E. and Morkin, E. Effects of thyroid hormone on alpha-actin and myosin heavy chain gene expression in cardiac and skeletal muscles of the rat: Measurement of mRNA content using synthetic oligonucleotide probes. Circ. Res. 59: 194–201, 1986
Gustafson, T.A., Bahl, J.J., Markham, B.E. et.al. Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. J. Biol. Chem. 262: 13,316 - 13,322, 1987
Yaffe, B.M. and Samuels, H.H. Hormonal regulation of the growth hormone gene. J. Biol. Chem. 259: 6284, 1984
Butler-Browne, G.S., Pruliere, G., Cambon, N. and Whalen, R.G. Influence of the dwarf mouse mutation on skeletal and cardiac myosin isoforms. J. Biol. Chem. 262: 15188–15193, 1987
Klein, I and Hong, C. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted heart. J. Clin. Invest. 77: 1694–1698, 1986
Korecky, B., Zak, R.,Schwartz, K. and Aschenbrenner, V. Role of thyroid hormone in regulation of isomyosin composition, contractility, and size of heterotopically isotransplanted rat heart. Circ. Res. 60: 824–830, 1987
Tada, M., Yamamoto, T. and Tonomura, Y. Molecular mechanism of active calcium transport by sarcoplasmic reticulum. Physiol. Rev. 58: 1–79, 1978
Suko, J. The calcium pump of sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits. J. Physiol. 228: 563–582, 1973
Limas, C.J. Calcium transport ATPase of cardiac sarcoplasmic reticulum in experimental hyperthyroidism. Am. J. Physiol. 235: H745 - H751, 1978
Takacs, I.E., Szabo, J., Nosztray, K. et. al. Alterations in contractility and sarcoplasmic reticulum function in rat heart in experimental hypo-and hyperthyroidism. Gen. Physiol. 4: 271–278, 1985
Black, S.C., McNeill, J.H. and Katz, S. Sarcoplasmic reticulum Cat+ transport and long chain acyl carnitines in hyperthyroidism. Can. J. Physiol. Pharmacol. 66: 159–165, 1988
McCallister, L.P. and Page, E. Effects of thyroxin on ultrastructure of rat myocardial cells: A stereological study. J. Ultrastructural Res. 42: 136–155, 1973
Rohrer, D. and Dillmann W.H. Thyroid hormone markedly increases the mRNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart. J. Biol. Chem. 263: 6941–6944, 1988
Sirlonides, W.S. and van Hardeveld, C. The postnatal development of sarcoplasmic reticulum Ca + transport activity in skeletal muscle of the rat is critically dependent on thyroid hormone. Endocrinology. 124: 1145–1153, 1989
Limas, C.J. Enhanced phosphorylation of myocardial sarcoplasmic reticulum in experimental hyperthyroidism. Am. J. Physiol. H426 - H431, 1978
Guarnieri, T., Filburn, C.R., Beard, E.S. and Lakatta, E.G. Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart. J. Clin Invest. 65: 861–868, 1980
Faas, F.H. and Carter, W.J. Fatty acid desaturation and microsomal lipid fatty acid composition in experimental hypothyroidism. Biochem. J. 207: 29–35, 1982
Stubbs, C.D. and Smith, A.D. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochem. Biophys. Acta. 779: 89137, 1984
Pitts, B.J.R., Tate, C.A., Van Winkle, B. et. al. Palmitoylcarnitine inhibition of the calcium pump in sarcoplasmic reticulum: a possible role in myocardial ischemia. Life Sci. 23: 391–402, 1978
Galo, M.G., Unates, L.E. and Fazas, R.N, Effect of membrane fatty acid composition on the action of thyroid hormones on (Ca 2++Mg2+)-adenosine triphosphatase from rat erythrocyte. J. Biol. Chem. 256: 7113–7114, 1981
Rupiinger, A., Mylotte, KM., Davis, P.J., Davis F.B. and Blas, S.D. Rabbit myocardial membrane Ca2+-adenosine triphosphatase activity: Stimulation in vitro by thyroid hormone. Arch. Biochem. Biophys. 229: 379–385, 1984
Segal, J. Adrenergic inhibition of the stimulatory effect of 3,5,3’-triiodothyronine on calcium accumulation and cytoplasmic free calcium concentration in rat thymocytes. Further evidence in support of the concept that calcium serves as the first messenger for the prompt action of thyroid hormone. Endocrinology. 122: 2240–2246, 1988
Segal, J., Hardiman, J. and Ingbar, S.H. Stimulation of calcium-ATPase activity by 3,5,3’triiodothyronine in rat thymocyte plasma membranes. Biochem. J. 261: 749–754, 1989
Coulumbe, P., Dussault, J.H. and Walker, P. Plasma catecholamine concentrations in hypothyroidism and hyperthyroidism. Metabolism. 25: 973–979, 1976
Bayliss, R.I.S. and Edwards, O.M. Urinary excretion of free catecholamines in Gravé s disease. Endocrinology. 49: 167–173, 1971
Bilezikian, J.P. and Loeb, J.N. The influence of hyperthyroidism and hypothyroidism on alpha-and beta-adrenergic receptor systems and adrenergic responsiveness. Endocrine Rev. 4: 378–388, 1983
Benfey, B.G. and Varma, D.R. Cardiac and vascular effects of sympathomimetic drugs after administration of tri-iodothyronine and reserpine. Br. J. Pharmacol. 21: 174–181, 1963
Margolius, H.S. and Gaffney, T.E. The effects of injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J. Pharmacol. Exp. Ther. 149: 329–335, 1965
van der Schoot, J.B. and Moran, N.C. An experimental evaluation of the reported influence of thyroxine on the cardiovascular effects of catecholamines. J. Pharamacol. Exp. Ther. 149: 336–345, 1965
Fox, A.W., Juberg, E.N., May, J.M. et.al. Thyroid status and adrenergic receptor subtypes in the rat: Comparison of receptor density and responsiveness. J. Pharmacol. Exp. Ther. 235: 715–723, 1985
Handberg, G.M. Influence of altered thyroid state on the inotropic potency of isoproterenolStudies with isolated rat left atria paced at different frequencies. J. Cardiovasc. Pharmacol. 6: 943–948, 1984
Hornbrook, K.R. and Cabral, A. Enhancement by thyroid hormone treatment of norepinephrineinduced phosphorylase activation in the rat heart. Biochem. Pharmacol. 21: 897–907, 1972
Young, B.A. and McNeill, J.H. The effect of noradrenaline and tyramine on cardiac contractility, cyclic AMP and phosphorylase a in normal and hyperthyroid rats. Can. J. Physiol. Pharmacol. 52: 373–383, 1974
Werth, D.K., Watanabe, A.M. and Hathaway, D.R. Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart. J. Mol. Cell. Cardiol. 15: 163–171, 1983
Tse, J., Wrenn, R.W. and Kuo, J.F. Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3’5’-monophosphate and guanosine 3’5’-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrinology. 107: 6–13, 1980
McNeill, J.H., Muschek, L.D. and Brody, T.M. The effect of triiodothyronine on cyclic AMP, phosphorylase and adenylcyclase in rat heart. Can. J. Physiol. Pharmacol. 47: 913–916, 1969
Ishac, E.J.N., Pennefather, J.N. and Handberg, G.M. Effect of changes in thyroid state on atrial alpha-and beta-adrenoceptors, adenylate cyclase activity, and catecholamine levels in the rat. J. Cardiovasc. Pharmacol. 5: 396–405, 1983
McNeill, J.H., LaRochelle, D.F. and Muschek, L.D. Theophylline potentiation of norepinephrine activated phosphorylase in normal and hyperthyroid rats. Arch. Int. Pharmacodyn. 193: 92–101, 1971
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Black, S.C., McNeill, J.H. (1990). Molecular and Subcellular Mechanisms of Thyroid Hormone Induced Cardiac Alterations. In: Korecky, B., Dhalla, N.S. (eds) Subcellular Basis of Contractile Failure. Developments in Cardiovascular Medicine, vol 116. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1513-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1513-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8813-8
Online ISBN: 978-1-4613-1513-1
eBook Packages: Springer Book Archive